calcitonin


Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.
Related to calcitonin: parathyroid hormone, Calcitriol, calcitonin test, calcitonin hormone

calcitonin

[kal·sə′tō·nən]
(biochemistry)
A polypeptide, calcium-regulating hormone produced by the ultimobranchial bodies in vertebrates. Also known as thyrocalcitonin.
References in periodicals archive ?
When measured with the Advantage system, calcitonin concentrations are higher in young infants than in adults; similar results have already been obtained with an isotopic method, which showed that concentrations are particularly high during the first week of life (4, 5), in low-birth-weight children (3), and in premature infants (6,8).
Calcitonin also decreased bone-specific alkaline phosphatase levels, compared with placebo, but to a lesser degree than did alendronate.
2] did not include data from more recent clinical trials of oral calcitonins, including Tarsa's oral calcitonin product.
nasal calcitonin prescriptions, down from the 48% August market share.
In October 2012, Tarsa presented data at the American Society for Bone and Mineral Research 2012 Annual Meeting assessing whether there was any sign of increased cancer risk in the 694 women who participated in the company's two separate year-long trials of its investigational oral calcitonin for the treatment and prevention of post-menopausal osteoporosis.
The Phase II results reinforce the findings of the Phase III ORACAL trial, which showed that Tarsa's oral calcitonin demonstrated superiority to both placebo and nasal calcitonin spray in increasing BMD at the lumbar spine after 48 weeks in postmenopausal women with osteoporosis.
Ashleigh Palmer, Chief Executive Officer, stated, "We are delighted with the positive results from Tarsa's study of oral calcitonin in postmenopausal women with osteopenia.
Tarsa's oral calcitonin has generated promising data in Phase II studies and the global Phase III clinical program is now underway.
Study Slated for Presentation at ASBMR 2012 Assesses Whether Tarsa's Oral Calcitonin Was Associated with Increased Cancer Risk in Two Year-Long Postmenopausal Osteoporosis Trials-
Nighttime Dosing May Increase Therapeutic Benefit of Calcitonin
The patient agreed to a trial of calcitonin therapy and after three days he reported that the burning pain had decreased significantly and was no longer troublesome.
today announced that Novartis Pharma AG and its license partner Nordic Bioscience a/s (the "Sponsor") have reported the following in connection with their Phase III Study 2302 in osteoarthritis assessing the safety and efficacy of oral calcitonin in the treatment of osteoarthritis of the knee.